Floatz logo

Humanized Cd7 Car-T Cells

T Lymphoblastic Leukemia/Lymphoma

The First Affiliated Hospital of Soochow UniversityCell therapyPhase 1/2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

49 Active assets in the T Lymphoblastic Leukemia/Lymphoma cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
Children's Oncology Group
Phase 3BB
Cytosin-Arabinosid
Princess Maxima Center for Pediatric Oncology
Phase 3BB
Cyclophosphamide
Children's Oncology Group
Phase 3BB
ETOPOSIDE
Children's Cancer Group, China
Phase 3BB
Daunorubicin
Children's Oncology Group
Phase 3B

View all 50 →

Same molecule, other indications

Humanized Cd7 Car-T Cells is also rated in:

T-cell non-Hodgkin lymphomaDormant
CCC
Indicative ·
53 / 100
View asset →
mixed phenotype acute leukemiaDormant
CC
Indicative ·
43 / 100
View asset →
acute myeloid leukemiaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →